$8.17
À la fermeture: Aug 18 EDT
$8.17
0.000.00%
Pré-commercialisation: 4:00 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Enanta Pharmaceuticals Inc (NASDAQ:ENTA) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 2.46M à 2.73M. Cela représente 13.57% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Enanta Pharma Corp (XNAS:ENTA) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 196.57K actions échangées par jour, il faudrait 13.9 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
2.73M
Intérêt à court terme %
13.6%
Jours de couverture
13.9
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ENTA | Enanta Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 13.57% | 20,122,779 | 2,731,581 | 196,572 | 13.9 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 12.24% | 20,122,779 | 2,463,124 | 157,567 | 15.63 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 12.05% | 20,122,779 | 2,423,818 | 138,920 | 17.45 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 12.42% | 20,122,779 | 2,498,915 | 237,356 | 10.53 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 13.53% | 20,122,779 | 2,721,617 | 105,008 | 25.92 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 14.19% | 20,122,779 | 2,854,687 | 134,930 | 21.16 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 14.73% | 20,078,742 | 2,957,157 | 181,451 | 16.3 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 13.96% | 20,078,742 | 2,803,726 | 315,454 | 8.89 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 13.28% | 20,078,742 | 2,667,145 | 201,024 | 13.27 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 13.11% | 20,078,742 | 2,632,482 | 262,336 | 10.03 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 12.94% | 20,078,742 | 2,598,257 | 523,491 | 4.96 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 17.79% | 20,078,742 | 3,572,627 | 603,837 | 5.92 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 16.76% | 20,078,742 | 3,364,560 | 366,653 | 9.18 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 16.22% | 19,933,548 | 3,232,743 | 741,016 | 4.36 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 16.79% | 19,933,548 | 3,347,388 | 717,663 | 4.66 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 16.91% | 19,933,548 | 3,371,327 | 575,287 | 5.86 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 16.21% | 19,933,548 | 3,231,310 | 311,534 | 10.37 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | 16.95% | 19,927,793 | 3,378,684 | 100,767 | 33.53 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 17.26% | 19,927,793 | 3,440,099 | 122,820 | 28.01 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 17.20% | 19,927,793 | 3,427,004 | 184,142 | 18.61 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 14.98% | 19,927,793 | 2,985,735 | 212,865 | 14.03 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 14.64% | 19,927,793 | 2,917,239 | 124,692 | 23.4 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 14.61% | 19,927,793 | 2,910,550 | 126,851 | 22.94 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/15/2024 | 08/26/2024 | 14.84% | 19,927,793 | 2,957,765 | 190,993 | 15.49 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 14.05% | 19,927,793 | 2,800,039 | 129,943 | 21.55 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 14.61% | 19,918,622 | 2,910,636 | 224,224 | 12.98 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 15.12% | 19,918,622 | 3,012,010 | 224,860 | 13.4 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 13.84% | 19,918,622 | 2,755,876 | 225,212 | 12.24 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 13.85% | 19,918,622 | 2,759,266 | 128,111 | 21.54 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 14.06% | 19,918,622 | 2,800,265 | 138,343 | 20.24 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 13.96% | 19,918,622 | 2,781,478 | 134,485 | 20.68 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 13.80% | 19,895,205 | 2,744,555 | 205,130 | 13.38 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 13.79% | 19,895,205 | 2,742,991 | 301,497 | 9.1 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 12.11% | 19,895,205 | 2,409,754 | 207,613 | 11.61 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 10.48% | 19,895,205 | 2,085,486 | 209,676 | 9.95 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/15/2024 | 02/27/2024 | 11.11% | 19,895,205 | 2,209,504 | 298,823 | 7.39 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 9.25% | 19,895,205 | 1,840,415 | 243,174 | 7.57 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 9.76% | 16,329,123 | 1,593,413 | 396,445 | 4.02 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 9.50% | 16,329,123 | 1,550,818 | 156,440 | 9.91 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 11.01% | 16,329,123 | 1,798,411 | 232,512 | 7.73 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 9.00% | 16,329,123 | 1,469,536 | 345,771 | 4.25 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 9.22% | 16,329,123 | 1,505,578 | 319,851 | 4.71 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 8.18% | 16,325,590 | 1,336,144 | 273,459 | 4.89 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/13/2023 | 10/24/2023 | 7.88% | 16,325,590 | 1,286,868 | 304,397 | 4.23 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/29/2023 | 10/10/2023 | 7.29% | 16,325,590 | 1,190,921 | 437,654 | 2.72 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/15/2023 | 09/26/2023 | 12.58% | 16,325,590 | 2,054,386 | 1,197,251 | 1.72 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/31/2023 | 09/12/2023 | 10.31% | 16,325,590 | 1,682,709 | 251,946 | 6.68 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/15/2023 | 08/24/2023 | 8.82% | 16,325,590 | 1,439,828 | 196,098 | 7.34 |
À la recherche des actions les plus vendues à découvert?